Nyxoah Sa (NYXH)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Nyxoah Sa Stock (NYXH) Company Profile

Healthcare (1176)

Prossima data di guadagno

Ultimi documenti SEC

NYXH's Discussions on Twitter

Confronta NYXH con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NYXH Nyxoah Sa	8.01	299.79M	4.71M	-46.77M	-60.34M	-1.6792
ISRG Intuitive Surgical Inc	524.43	186.79B	7.87B	2.24B	586.00M	6.22
BDX Becton Dickinson Co	227.68	65.83B	20.18B	1.71B	3.07B	5.94
ALC Alcon Inc	84.76	41.92B	9.76B	1.16B	665.00M	2.34
RMD Resmed Inc	237.27	34.83B	4.81B	1.11B	1.35B	7.55
WST West Pharmaceutical Services Inc	331.40	24.00B	2.88B	499.60M	321.60M	6.74

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-07-31	Iniziato	H.C. Wainwright	Buy
2023-07-19	Iniziato	Robert W. Baird	Neutral
2022-04-21	Iniziato	Oppenheimer	Outperform
2022-04-06	Iniziato	Wolfe Research	Peer Perform
2021-12-21	Ripresa	Cantor Fitzgerald	Overweight
2021-07-28	Iniziato	Cantor Fitzgerald	Overweight

Mostra tutto

Nyxoah Sa Borsa (NYXH) Ultime notizie

Nyxoah Sa Azioni (NYXH) Dati Finanziari

Nyxoah Sa (NYXH)

Nyxoah Sa Stock (NYXH) Company Profile

Confronta NYXH con altri titoli

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Nyxoah Sa Borsa (NYXH) Ultime notizie

Publication relating to transparency notifications - GlobeNewswire

BlackRock Takes 3% Stake in Medical Device Maker Nyxoah in Strategic Investment Move - StockTitan

(NYXH) Investment Analysis and Advice - Stock Traders Daily

Nyxoah's SWOT analysis: sleep apnea innovator faces growth hurdles - Investing.com

Nyxoah's SWOT analysis: sleep apnea innovator faces growth hurdles By Investing.com - Investing.com UK

Nyxoah's nerve stimulation device meets endpoints in sleep apnoea studyMedical Device Network - Oficjalny Portal Gminy Brzesko

Nyxoah’s Genio Neurostimulator for OSA Launches in England - Sleep Review

Nyxoah's SWOT analysis: sleep apnea innovator's stock poised for US launch - Investing.com

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England - GlobeNewswire

Nyxoah Launches Revolutionary Sleep Apnea Treatment in England with First NHS-Covered Implants - StockTitan

Where are the Opportunities in (NYXH) - Stock Traders Daily

Nyxoah Updates Share Capital and Voting Rights - TipRanks

Information on the Total Number of Voting Rights And Shares: Nyxoah - The Korea Bizwire

Information on the total number of voting rights and shares - GlobeNewswire

Objective long/short (NYXH) Report - Stock Traders Daily

Nyxoah (NASDAQ:NYXH) vs. Alpha Tau Medical (NASDAQ:DRTS) Head to Head Contrast - Defense World

Nyxoah to Present at Healthcare Conference Amidst Growth - TipRanks

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Manila Times

Nyxoah to Present Sleep Apnea Innovation at Piper Sandler Healthcare Conference | NYXH Stock News - StockTitan

Nyxoah SA (NYXH) Reports Q3 Loss, Tops Revenue Estimates - MSN

Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024: Nyxoah - The Korea Bizwire

Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024 - GlobeNewswire

Nyxoah Schedules Special Meeting to Vote on EIB Loan Agreement Terms | NYXH Stock News - StockTitan

Publication Relating to Transparency Notifications: Nyxoah - The Korea Bizwire

Nyxoah’s Voting Rights Shift with ResMed Stake - TipRanks

ResMed's Stake in Nyxoah Drops Below 5% Threshold in Latest Holdings Update | NYXH Stock News - StockTitan

Nyxoah S.A. (NASDAQ:NYXH) Short Interest Down 17.4% in October - MarketBeat

Nyxoah's SWOT analysis: sleep apnea device maker's stock poised for growth - Investing.com India

Nyxoah Third Quarter 2024 Earnings: €0.50 loss per share (vs €0.27 loss in 3Q 2023) - Simply Wall St

Nyxoah Reports Third Quarter Financial and Operating Results - Wahanariau

Nyxoah sales jump 30% to €1.3 million in Q3 2024 - Medical Buyer

Nyxoah SA Reports Growth Amid Clinical Advances - TipRanks

EQS-News: Nyxoah Reports Third Quarter Financial and Operating Results - sharewise

Nyxoah Eyes Strong US Launch Amid Financial Growth - TipRanks

Nyxoah S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nyxoah Reports Third Quarter Financial and Operating Results, Business Wires News - AsiaOne

(NYXH) Investment Report - Stock Traders Daily

Nyxoah SA (NYXH) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Nyxoah Appoints John Landry as Chief Financial Officer - The Manila Times

Nyxoah SA Announces CFO Changes - Marketscreener.com

Nyxoah participates in a conference call with Cantor Fitzgerald - TipRanks

Nyxoah SA (NYXH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - MSN

Trend Tracker for (NYXH) - Stock Traders Daily

Publication relating to transparency notifications: Nyxoah - The Korea Bizwire

Transparency Notification: Vestal Point Capital’s Stake in Nyxoah - PanAsiaBiz

Publication relating to transparency notifications, Business Wires News - AsiaOne

NYXHNyxoah SA Ordinary Shares Latest Stock News & Market Updates - StockTitan

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024, Business Wires News - AsiaOne

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 - The Manila Times

Behind the Bell: Nyxoah SA - Nasdaq

Nyxoah raises $27M for US commercialization of sleep apnea technology​ - BioWorld Online

Nyxoah Sa Azioni (NYXH) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a NYXH

Nyxoah raises $27M for US commercialization of sleep apnea technology - BioWorld Online